Carpal Tunnel Clinical Trials 2023

Carpal Tunnel Clinical Trials 2023

Carpal Tunnel research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in carpal tunnel clinical trials today.

Trials for CTS Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to carpal tunnel

What are the top hospitals conducting carpal tunnel research?

Carpal tunnel syndrome is a common condition that affects millions of individuals worldwide, causing pain and discomfort in the hands and wrists. Thankfully, several top hospitals are dedicated to finding innovative treatments through clinical trials. One such institution is the Mayo Clinic in Rochester, known for its cutting-edge research. Currently, they have three active carpal tunnel trials and have conducted five studies overall since their first recorded trial in 2014. In Boston, Massachusetts General Hospital stands out with two ongoing carpal tunnel trials and a total of five completed studies since their initial trial in 2009.

Moving to Chicago, the University of Chicago Medicine joins this list with one active carpal tunnel trial and one completed study thus far—both being remarkable achievements considering their relatively recent entry into this field, beginning only in 2023. Similarly contributing to the advancement of knowledge on carpal tunnel syndrome is Bluegrass Orthopaedics based in Lexington; despite having just initiated their first recorded trial also during 2023, they are already making strides with one ongoing clinical investigation.

Finally making its mark within this domain is none other than the University of Nevada located amidst Las Vegas's vibrant atmosphere where emerging medical professionals contribute towards combating this ailment as well.They currently run an active carpal tunnel trial alongside their inaugural case dating back barely few years ago-also commencing during late2023.Even though considered rather new entrants into these respective areas both remain poised to play vital roles toward addressing this widespread issue.

These hospitals represent beacons of hope for those suffering from carpal tunnel syndrome by striving tirelessly to find better treatment options through rigorous scientific inquiry. Their commitment showcases not only dedication but also our collective pursuit for improved quality of life—one step at a time

Which are the best cities for carpal tunnel clinical trials?

When it comes to carpal tunnel clinical trials, several cities have emerged as leaders in researching and developing new treatments. Rochester, Minnesota stands out with its three active trials focusing on interventions like Fisetin, FDA approved ultrasound systems with shear wave elastography capability, and wound closure techniques. Boston, Massachusetts follows closely behind with two ongoing studies investigating CTR-US and acupuncture - distal methods. Additionally, Chicago, Illinois; Lexington, Kentucky; and Las Vegas, Nevada each have one active trial centered around innovative approaches such as experimental ice therapy or CTR-US. These cities provide individuals suffering from carpal tunnel syndrome access to cutting-edge clinical research that may lead to improved treatment options and enhanced quality of life.

Which are the top treatments for carpal tunnel being explored in clinical trials?

In the realm of carpal tunnel treatment, clinical trials are currently exploring several promising options. Among them are:

  • CTR-US: This innovative treatment is being tested in two active trials and has shown potential in one all-time carpal tunnel trial since its introduction in 2022.
  • Fisetin: Another contender on the horizon, fisetin is making waves with its involvement in one ongoing trial and one all-time carpal tunnel trial since 2022.
  • FDA approved ultrasound system with shear wave elastography capability: This cutting-edge technology has caught the attention of researchers, participating in one active and one all-time carpal tunnel trial ever since it was first listed back in 2021.
  • Transcranial Direct Current Stimulation (tdcs): Emerging as a potentially effective option for carpal tunnel, tDCS is currently involved in one active trial along with an all-time carpal tunnel trial initiated in 2021.

These treatments offer hope to individuals suffering from this debilitating condition by paving the way for future advancements and improved quality of life.

What are the most recent clinical trials for carpal tunnel?

New research and clinical trials offer hope for those suffering from carpal tunnel syndrome, a common condition that causes pain and numbness in the hand and wrist. One recent study investigated the potential benefits of fisetin, a natural compound known for its anti-inflammatory properties. Another trial explored the use of N-acetyl cysteine to alleviate symptoms associated with carpal tunnel. Additionally, researchers examined the effectiveness of wrist splints in managing this condition. Conditioning electrical stimulation was also investigated as a potential treatment option. Finally, a study focused on comparing different pain management strategies for carpal tunnel syndrome. These exciting developments showcase ongoing efforts to improve care and enhance quality of life for individuals affected by this debilitating condition.

What carpal tunnel clinical trials were recently completed?

Recently, several clinical trials investigating treatments for carpal tunnel syndrome have concluded. These studies aimed to uncover new and effective therapies for this common condition that causes pain and numbness in the hand and wrist. Researchers conducted a trial testing the efficacy of a drug called Neurogel, which was completed in October 2021. The National Institute of Neurological Disorders and Stroke (NINDS) also sponsored a trial examining the effectiveness of physical therapy interventions, which concluded in September 2021. Another study focused on evaluating the benefits of acupuncture as a potential treatment option for carpal tunnel syndrome, wrapping up in January 2021. These recent advancements provide valuable insights into improving care for individuals suffering from this debilitating condition.